Although these results highlight the expression of TRPA1 as important in cancer progression from stage 1 to stage 3, the results are mirrored by significant changes in clinical parameters such as overall survival only in BRCA-Her2, KICH and READ cancers, where TIMER.2 returns a z score indicating a good prognosis (bold red values, left side of Figure 3B). This evidence concerns the gene ERBB2 and cancer.